Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)
Conditions: Hepatocellular Carcinoma Interventions: Radiation: Stereotactic body radiotherapy; Drug: Sintilimab Sponsors: Sun Yat-sen University; Fifth Affiliated Hospital, Sun Yat-Sen University; Ningbo Medical Center Lihuili Eastern Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Immunotherapy | Liver Cancer | Research